Ocugen Inc (OCGN)
0.955
-0.04
(-4.50%)
USD |
NASDAQ |
Nov 15, 10:55
Ocugen Cash from Operations (Quarterly): -9.911M for June 30, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -9.911M |
| March 31, 2024 | -10.60M |
| December 31, 2023 | -11.30M |
| September 30, 2023 | -13.71M |
| June 30, 2023 | -18.81M |
| March 31, 2023 | -18.24M |
| December 31, 2022 | -16.91M |
| September 30, 2022 | -14.30M |
| June 30, 2022 | -13.80M |
| March 31, 2022 | -15.07M |
| December 31, 2021 | -12.80M |
| September 30, 2021 | -8.053M |
| June 30, 2021 | -21.80M |
| March 31, 2021 | -5.283M |
| December 31, 2020 | -4.283M |
| September 30, 2020 | -2.653M |
| June 30, 2020 | -3.087M |
| March 31, 2020 | -4.686M |
| December 31, 2019 | -8.744M |
| September 30, 2019 | 3.400M |
| June 30, 2019 | -3.057M |
| Date | Value |
|---|---|
| March 31, 2019 | -8.492M |
| December 31, 2018 | -6.938M |
| September 30, 2018 | -6.912M |
| June 30, 2018 | -5.213M |
| March 31, 2018 | 3.286M |
| December 31, 2017 | -4.319M |
| September 30, 2017 | -5.727M |
| June 30, 2017 | -5.629M |
| March 31, 2017 | -7.345M |
| December 31, 2016 | -5.893M |
| September 30, 2016 | -5.459M |
| June 30, 2016 | -6.543M |
| March 31, 2016 | -7.841M |
| December 31, 2015 | -6.997M |
| September 30, 2015 | -6.882M |
| June 30, 2015 | -7.466M |
| March 31, 2015 | -8.689M |
| December 31, 2014 | -4.678M |
| September 30, 2014 | -2.795M |
| June 30, 2014 | -5.446M |
| March 31, 2014 | -5.019M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-21.80M
Minimum
Jun 2021
-2.653M
Maximum
Sep 2020
-11.26M
Average
-11.30M
Median
Dec 2023
Cash from Operations (Quarterly) Benchmarks
| Cytokinetics Inc | -101.50M |
| Scholar Rock Holding Corp | -49.20M |
| Mirum Pharmaceuticals Inc | -3.803M |
| SpringWorks Therapeutics Inc | -41.79M |
| NeuroBo Pharmaceuticals Inc | -5.589M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -0.513M |
| Cash from Financing (Quarterly) | 0.045M |
| Free Cash Flow | -54.47M |
| Free Cash Flow Per Share (Quarterly) | -0.0405 |
| Free Cash Flow to Equity (Quarterly) | -10.45M |
| Free Cash Flow Yield | -21.52% |